Bruce Bender
Concepts (384)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Asthma | 85 | 2023 | 2152 | 11.200 |
Why?
| Patient Compliance | 25 | 2020 | 524 | 4.870 |
Why?
| Anti-Asthmatic Agents | 20 | 2022 | 350 | 4.520 |
Why?
| Medication Adherence | 24 | 2022 | 536 | 4.390 |
Why?
| Adrenal Cortex Hormones | 21 | 2022 | 510 | 2.340 |
Why?
| Pulmonary Disease, Chronic Obstructive | 10 | 2023 | 1115 | 1.980 |
Why?
| Telemedicine | 8 | 2022 | 667 | 1.900 |
Why?
| Bronchodilator Agents | 8 | 2020 | 251 | 1.730 |
Why?
| Food Hypersensitivity | 4 | 2020 | 254 | 1.640 |
Why?
| Dermatitis, Atopic | 8 | 2018 | 337 | 1.560 |
Why?
| Electronic Mail | 2 | 2021 | 54 | 1.450 |
Why?
| Health Personnel | 4 | 2021 | 578 | 1.300 |
Why?
| Adrenergic beta-Agonists | 3 | 2020 | 129 | 1.290 |
Why?
| Patient Education as Topic | 9 | 2021 | 686 | 1.240 |
Why?
| Health Communication | 2 | 2018 | 41 | 1.190 |
Why?
| Self Care | 7 | 2021 | 354 | 1.180 |
Why?
| Humans | 123 | 2023 | 115908 | 1.140 |
Why?
| Speech Recognition Software | 2 | 2018 | 11 | 1.140 |
Why?
| Rhinitis, Allergic | 2 | 2018 | 37 | 1.080 |
Why?
| Child | 50 | 2023 | 18555 | 0.960 |
Why?
| Administration, Inhalation | 18 | 2023 | 647 | 0.950 |
Why?
| Stress, Psychological | 5 | 2018 | 975 | 0.940 |
Why?
| Disease Management | 3 | 2018 | 562 | 0.940 |
Why?
| Bullying | 2 | 2016 | 22 | 0.900 |
Why?
| Metered Dose Inhalers | 5 | 2012 | 14 | 0.890 |
Why?
| Anti-Allergic Agents | 3 | 2018 | 41 | 0.890 |
Why?
| Glucocorticoids | 4 | 2016 | 551 | 0.890 |
Why?
| Parents | 12 | 2022 | 1210 | 0.860 |
Why?
| Reminder Systems | 3 | 2015 | 162 | 0.850 |
Why?
| Communication | 3 | 2021 | 749 | 0.830 |
Why?
| Cell Phone | 2 | 2021 | 78 | 0.820 |
Why?
| Sleep Wake Disorders | 7 | 2016 | 234 | 0.770 |
Why?
| Personnel Management | 1 | 2021 | 11 | 0.770 |
Why?
| Text Messaging | 2 | 2020 | 154 | 0.750 |
Why?
| Tobacco Products | 1 | 2022 | 68 | 0.750 |
Why?
| Telecommunications | 2 | 2018 | 16 | 0.740 |
Why?
| Rhinitis, Allergic, Seasonal | 3 | 2005 | 33 | 0.740 |
Why?
| Monitoring, Physiologic | 3 | 2019 | 252 | 0.730 |
Why?
| Delivery of Health Care | 5 | 2023 | 847 | 0.720 |
Why?
| Research Design | 4 | 2023 | 947 | 0.710 |
Why?
| Self-Management | 2 | 2019 | 126 | 0.710 |
Why?
| Electronic Health Records | 2 | 2018 | 801 | 0.700 |
Why?
| Nurse-Patient Relations | 1 | 2020 | 45 | 0.690 |
Why?
| Biological Products | 1 | 2022 | 172 | 0.680 |
Why?
| Quality of Life | 12 | 2020 | 2392 | 0.670 |
Why?
| Minority Groups | 5 | 2017 | 232 | 0.670 |
Why?
| Treatment Adherence and Compliance | 1 | 2019 | 19 | 0.670 |
Why?
| Workload | 1 | 2020 | 132 | 0.650 |
Why?
| Organizational Culture | 1 | 2020 | 121 | 0.650 |
Why?
| Hypersensitivity | 3 | 2022 | 272 | 0.650 |
Why?
| Adrenergic beta-2 Receptor Agonists | 2 | 2019 | 34 | 0.640 |
Why?
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2015 | 101 | 0.640 |
Why?
| Prescription Drug Overuse | 1 | 2018 | 11 | 0.630 |
Why?
| Health Behavior | 3 | 2013 | 707 | 0.620 |
Why?
| Substance-Related Disorders | 2 | 2022 | 953 | 0.620 |
Why?
| Motivation | 2 | 2020 | 496 | 0.610 |
Why?
| Behavioral Medicine | 1 | 2018 | 37 | 0.610 |
Why?
| Health Promotion | 2 | 2014 | 690 | 0.600 |
Why?
| Urticaria | 1 | 2018 | 51 | 0.600 |
Why?
| Androstadienes | 3 | 2008 | 97 | 0.570 |
Why?
| Spirometry | 5 | 2021 | 256 | 0.570 |
Why?
| Fluticasone-Salmeterol Drug Combination | 1 | 2016 | 12 | 0.560 |
Why?
| Laryngeal Diseases | 1 | 2016 | 19 | 0.560 |
Why?
| Male | 53 | 2022 | 56128 | 0.560 |
Why?
| Tobacco Smoke Pollution | 2 | 2014 | 221 | 0.560 |
Why?
| Physician-Patient Relations | 4 | 2014 | 466 | 0.550 |
Why?
| Adaptation, Psychological | 2 | 2018 | 551 | 0.540 |
Why?
| Female | 55 | 2022 | 60086 | 0.540 |
Why?
| Surveys and Questionnaires | 15 | 2021 | 4670 | 0.530 |
Why?
| Science | 1 | 2016 | 49 | 0.520 |
Why?
| Laryngoscopy | 1 | 2016 | 93 | 0.520 |
Why?
| Primary Health Care | 5 | 2021 | 1517 | 0.520 |
Why?
| Behavior Therapy | 1 | 2018 | 227 | 0.520 |
Why?
| Anxiety | 5 | 2016 | 853 | 0.520 |
Why?
| Adolescent | 29 | 2022 | 17955 | 0.520 |
Why?
| Desensitization, Immunologic | 2 | 2018 | 117 | 0.510 |
Why?
| Research Report | 1 | 2015 | 76 | 0.500 |
Why?
| Telephone | 3 | 2020 | 153 | 0.490 |
Why?
| Pulmonary Medicine | 2 | 2016 | 88 | 0.480 |
Why?
| Airway Obstruction | 1 | 2016 | 170 | 0.480 |
Why?
| Clinical Trials as Topic | 2 | 2012 | 945 | 0.470 |
Why?
| Sublingual Immunotherapy | 1 | 2014 | 7 | 0.470 |
Why?
| Diagnostic Techniques and Procedures | 1 | 2014 | 13 | 0.470 |
Why?
| Adult | 26 | 2023 | 30820 | 0.460 |
Why?
| Therapeutics | 1 | 2014 | 12 | 0.460 |
Why?
| Pruritus | 4 | 2010 | 61 | 0.460 |
Why?
| Community-Institutional Relations | 1 | 2014 | 89 | 0.460 |
Why?
| Quality of Health Care | 1 | 2018 | 578 | 0.460 |
Why?
| Motivational Interviewing | 1 | 2014 | 87 | 0.430 |
Why?
| Depression | 6 | 2018 | 1149 | 0.420 |
Why?
| Family | 4 | 2022 | 591 | 0.420 |
Why?
| Oxygen Inhalation Therapy | 1 | 2014 | 130 | 0.420 |
Why?
| Nebulizers and Vaporizers | 5 | 2023 | 80 | 0.410 |
Why?
| United States | 13 | 2021 | 12338 | 0.390 |
Why?
| Organizational Affiliation | 1 | 2011 | 8 | 0.390 |
Why?
| Behavioral Research | 1 | 2011 | 34 | 0.380 |
Why?
| Psychomotor Performance | 2 | 2004 | 278 | 0.380 |
Why?
| Socioeconomic Factors | 6 | 2022 | 1090 | 0.380 |
Why?
| Severity of Illness Index | 10 | 2019 | 2598 | 0.380 |
Why?
| Physical Therapy Modalities | 1 | 2014 | 270 | 0.370 |
Why?
| Budesonide | 5 | 2012 | 87 | 0.370 |
Why?
| Reinforcement, Verbal | 1 | 2010 | 2 | 0.360 |
Why?
| Art Therapy | 1 | 2010 | 14 | 0.360 |
Why?
| Health Services Accessibility | 2 | 2015 | 771 | 0.350 |
Why?
| Patient Participation | 2 | 2018 | 362 | 0.350 |
Why?
| Middle Aged | 21 | 2020 | 27084 | 0.340 |
Why?
| Intensive Care Units | 1 | 2014 | 616 | 0.340 |
Why?
| Critical Care | 3 | 2021 | 476 | 0.340 |
Why?
| Chronic Disease | 6 | 2018 | 1602 | 0.330 |
Why?
| Focus Groups | 3 | 2011 | 386 | 0.330 |
Why?
| Curriculum | 1 | 2015 | 853 | 0.330 |
Why?
| Child, Preschool | 13 | 2021 | 9175 | 0.320 |
Why?
| Pain | 1 | 2014 | 713 | 0.310 |
Why?
| Retrospective Studies | 7 | 2023 | 12616 | 0.310 |
Why?
| Evidence-Based Medicine | 3 | 2021 | 686 | 0.300 |
Why?
| Fluticasone | 4 | 2018 | 87 | 0.300 |
Why?
| Cognition Disorders | 4 | 2014 | 478 | 0.300 |
Why?
| Young Adult | 9 | 2022 | 10518 | 0.300 |
Why?
| Technology | 2 | 2018 | 77 | 0.300 |
Why?
| Sleep | 3 | 2008 | 626 | 0.290 |
Why?
| Clinical Decision-Making | 2 | 2021 | 275 | 0.290 |
Why?
| Histamine H1 Antagonists | 2 | 2005 | 33 | 0.280 |
Why?
| Environmental Exposure | 2 | 2018 | 381 | 0.280 |
Why?
| Health Literacy | 3 | 2021 | 166 | 0.280 |
Why?
| Qualitative Research | 2 | 2020 | 964 | 0.280 |
Why?
| Exercise | 1 | 2016 | 1611 | 0.270 |
Why?
| Prednisone | 5 | 2022 | 232 | 0.270 |
Why?
| Albuterol | 1 | 2006 | 106 | 0.270 |
Why?
| Rhinitis, Allergic, Perennial | 1 | 2005 | 24 | 0.260 |
Why?
| Guideline Adherence | 2 | 2021 | 494 | 0.260 |
Why?
| Sex Chromosome Aberrations | 2 | 2002 | 51 | 0.250 |
Why?
| Mood Disorders | 1 | 2006 | 117 | 0.250 |
Why?
| Health Expenditures | 2 | 2016 | 174 | 0.250 |
Why?
| Health Knowledge, Attitudes, Practice | 5 | 2016 | 1193 | 0.240 |
Why?
| Social Class | 2 | 2022 | 213 | 0.240 |
Why?
| Caregivers | 2 | 2016 | 714 | 0.240 |
Why?
| Data Collection | 1 | 2007 | 636 | 0.240 |
Why?
| Colorado | 6 | 2020 | 4122 | 0.240 |
Why?
| Loratadine | 1 | 2004 | 3 | 0.240 |
Why?
| Hospitalization | 6 | 2020 | 1761 | 0.230 |
Why?
| Sleep Stages | 1 | 2004 | 61 | 0.230 |
Why?
| Health Resources | 2 | 2016 | 122 | 0.230 |
Why?
| Biomedical Research | 2 | 2021 | 590 | 0.230 |
Why?
| Salmeterol Xinafoate | 2 | 2018 | 42 | 0.230 |
Why?
| Overweight | 1 | 2007 | 468 | 0.220 |
Why?
| Histamine H1 Antagonists, Non-Sedating | 1 | 2003 | 1 | 0.220 |
Why?
| Research | 3 | 2016 | 398 | 0.220 |
Why?
| Nitric Oxide | 2 | 2019 | 834 | 0.220 |
Why?
| Diphenhydramine | 1 | 2003 | 30 | 0.220 |
Why?
| Patient Dropouts | 1 | 2003 | 65 | 0.220 |
Why?
| Risk-Taking | 1 | 2006 | 333 | 0.210 |
Why?
| Animals, Domestic | 1 | 2002 | 11 | 0.210 |
Why?
| Social Support | 4 | 2013 | 541 | 0.210 |
Why?
| Emotions | 2 | 2018 | 486 | 0.210 |
Why?
| Hypnotics and Sedatives | 1 | 2003 | 134 | 0.200 |
Why?
| Age Factors | 5 | 2016 | 2912 | 0.200 |
Why?
| Income | 1 | 2022 | 170 | 0.200 |
Why?
| Cost-Benefit Analysis | 2 | 2015 | 545 | 0.190 |
Why?
| Tobacco Use | 1 | 2022 | 61 | 0.190 |
Why?
| Health Services Needs and Demand | 1 | 2023 | 248 | 0.190 |
Why?
| Thoracic Diseases | 1 | 2021 | 13 | 0.190 |
Why?
| Adolescent Behavior | 1 | 2006 | 483 | 0.190 |
Why?
| Nedocromil | 3 | 2009 | 32 | 0.180 |
Why?
| Observational Studies as Topic | 1 | 2021 | 89 | 0.180 |
Why?
| Smartphone | 2 | 2018 | 68 | 0.180 |
Why?
| Quality Improvement | 2 | 2019 | 956 | 0.170 |
Why?
| Prospective Studies | 7 | 2022 | 6267 | 0.170 |
Why?
| Models, Econometric | 1 | 2019 | 34 | 0.170 |
Why?
| Risk Factors | 8 | 2014 | 8714 | 0.170 |
Why?
| Behavior Control | 1 | 2019 | 14 | 0.170 |
Why?
| Intelligence | 4 | 2007 | 134 | 0.160 |
Why?
| Patient-Centered Care | 2 | 2016 | 475 | 0.160 |
Why?
| Telemetry | 1 | 2018 | 35 | 0.160 |
Why?
| Allergists | 1 | 2018 | 19 | 0.160 |
Why?
| Receptor, ErbB-4 | 1 | 2018 | 19 | 0.160 |
Why?
| Drug Monitoring | 1 | 2019 | 184 | 0.160 |
Why?
| Exhalation | 1 | 2018 | 35 | 0.160 |
Why?
| Citalopram | 1 | 2018 | 27 | 0.150 |
Why?
| Cloud Computing | 1 | 2017 | 8 | 0.150 |
Why?
| Randomized Controlled Trials as Topic | 3 | 2016 | 1216 | 0.150 |
Why?
| Antidepressive Agents, Second-Generation | 1 | 2018 | 38 | 0.150 |
Why?
| Confidentiality | 1 | 2018 | 67 | 0.150 |
Why?
| Patient Advocacy | 2 | 2020 | 66 | 0.150 |
Why?
| Respiratory System | 1 | 2019 | 141 | 0.150 |
Why?
| Health Plan Implementation | 1 | 2019 | 133 | 0.150 |
Why?
| Aged | 8 | 2019 | 19299 | 0.150 |
Why?
| Medical Informatics | 1 | 2018 | 94 | 0.150 |
Why?
| Respiratory Tract Diseases | 1 | 2018 | 142 | 0.140 |
Why?
| Health Surveys | 2 | 2009 | 449 | 0.140 |
Why?
| Biosensing Techniques | 1 | 2018 | 102 | 0.140 |
Why?
| Dry Powder Inhalers | 1 | 2016 | 2 | 0.140 |
Why?
| Sleep Medicine Specialty | 1 | 2016 | 9 | 0.140 |
Why?
| Suicidal Ideation | 2 | 2012 | 399 | 0.140 |
Why?
| Adrenergic beta-Antagonists | 1 | 2018 | 293 | 0.140 |
Why?
| Larynx | 1 | 2016 | 48 | 0.140 |
Why?
| Time Factors | 2 | 2021 | 6186 | 0.130 |
Why?
| Practice Guidelines as Topic | 4 | 2021 | 1403 | 0.130 |
Why?
| Respiration | 1 | 2016 | 180 | 0.130 |
Why?
| Air Pollution | 1 | 2018 | 183 | 0.130 |
Why?
| Health Education | 1 | 2018 | 317 | 0.130 |
Why?
| Mental Disorders | 2 | 2014 | 908 | 0.130 |
Why?
| Health Services | 1 | 2016 | 105 | 0.130 |
Why?
| Pilot Projects | 3 | 2013 | 1374 | 0.130 |
Why?
| Problem Behavior | 1 | 2016 | 86 | 0.130 |
Why?
| Treatment Outcome | 8 | 2018 | 9166 | 0.130 |
Why?
| Intention to Treat Analysis | 1 | 2015 | 69 | 0.130 |
Why?
| Anti-Inflammatory Agents | 3 | 2010 | 447 | 0.120 |
Why?
| Self Efficacy | 1 | 2018 | 361 | 0.120 |
Why?
| Depressive Disorder, Major | 1 | 2018 | 307 | 0.120 |
Why?
| Physicians | 1 | 2022 | 774 | 0.120 |
Why?
| Patient Reported Outcome Measures | 1 | 2016 | 251 | 0.120 |
Why?
| Patient Acceptance of Health Care | 3 | 2015 | 682 | 0.120 |
Why?
| Psychology | 1 | 2014 | 83 | 0.120 |
Why?
| Monosomy | 2 | 2004 | 10 | 0.120 |
Why?
| Follow-Up Studies | 4 | 2014 | 4446 | 0.110 |
Why?
| Pandemics | 1 | 2022 | 1333 | 0.110 |
Why?
| Chromosomes, Human, X | 2 | 2004 | 60 | 0.110 |
Why?
| Sex Factors | 3 | 2009 | 1741 | 0.110 |
Why?
| Community Health Services | 1 | 2015 | 212 | 0.110 |
Why?
| Cost Savings | 1 | 2013 | 74 | 0.110 |
Why?
| Aged, 80 and over | 3 | 2016 | 6438 | 0.110 |
Why?
| Referral and Consultation | 1 | 2018 | 647 | 0.110 |
Why?
| Administration, Oral | 3 | 2018 | 731 | 0.110 |
Why?
| Turner Syndrome | 2 | 2004 | 45 | 0.110 |
Why?
| Indians, North American | 1 | 2018 | 593 | 0.110 |
Why?
| Self Report | 2 | 2019 | 701 | 0.100 |
Why?
| Lung Diseases | 2 | 2016 | 710 | 0.100 |
Why?
| Ethanolamines | 1 | 2012 | 20 | 0.100 |
Why?
| Emergency Service, Hospital | 2 | 2021 | 1842 | 0.100 |
Why?
| Primary Prevention | 1 | 2013 | 171 | 0.100 |
Why?
| Multimedia | 1 | 2011 | 10 | 0.100 |
Why?
| Program Evaluation | 2 | 2019 | 839 | 0.100 |
Why?
| Thinking | 1 | 2012 | 54 | 0.100 |
Why?
| Equipment Design | 3 | 2020 | 516 | 0.100 |
Why?
| Needs Assessment | 1 | 2013 | 320 | 0.100 |
Why?
| Immunotherapy | 1 | 2015 | 480 | 0.090 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2018 | 2020 | 0.090 |
Why?
| Sickness Impact Profile | 1 | 2010 | 50 | 0.090 |
Why?
| Longitudinal Studies | 3 | 2007 | 2437 | 0.090 |
Why?
| Drug Therapy, Combination | 3 | 2012 | 961 | 0.090 |
Why?
| Patient Satisfaction | 3 | 2022 | 585 | 0.090 |
Why?
| Forced Expiratory Volume | 3 | 2013 | 522 | 0.080 |
Why?
| Continuity of Patient Care | 1 | 2011 | 254 | 0.080 |
Why?
| Comorbidity | 1 | 2014 | 1476 | 0.080 |
Why?
| Interdisciplinary Communication | 1 | 2010 | 185 | 0.080 |
Why?
| Infant | 3 | 2021 | 8002 | 0.080 |
Why?
| Program Development | 1 | 2011 | 349 | 0.080 |
Why?
| Peer Group | 2 | 2013 | 208 | 0.080 |
Why?
| Cooperative Behavior | 1 | 2011 | 390 | 0.080 |
Why?
| Animals | 4 | 2018 | 32123 | 0.080 |
Why?
| Inflammation | 1 | 2019 | 2503 | 0.080 |
Why?
| Activity Cycles | 1 | 2008 | 4 | 0.080 |
Why?
| Odds Ratio | 2 | 2009 | 969 | 0.080 |
Why?
| Affect | 2 | 2014 | 244 | 0.080 |
Why?
| Incidence | 2 | 2014 | 2333 | 0.080 |
Why?
| Beclomethasone | 1 | 2008 | 25 | 0.080 |
Why?
| Smoking | 2 | 2007 | 1468 | 0.070 |
Why?
| Patients | 1 | 2009 | 164 | 0.070 |
Why?
| Cohort Studies | 3 | 2013 | 4960 | 0.070 |
Why?
| Schools | 1 | 2010 | 401 | 0.070 |
Why?
| Computers | 1 | 2007 | 61 | 0.070 |
Why?
| Polysomnography | 1 | 2008 | 135 | 0.070 |
Why?
| Self Disclosure | 1 | 2007 | 59 | 0.070 |
Why?
| Social Isolation | 1 | 2007 | 55 | 0.070 |
Why?
| Monitoring, Ambulatory | 1 | 2008 | 82 | 0.070 |
Why?
| Culture | 1 | 2008 | 126 | 0.070 |
Why?
| Practice Patterns, Physicians' | 1 | 2015 | 1177 | 0.070 |
Why?
| Double-Blind Method | 2 | 2018 | 1665 | 0.070 |
Why?
| Cocaine-Related Disorders | 1 | 2007 | 107 | 0.070 |
Why?
| Child Behavior Disorders | 1 | 2007 | 128 | 0.070 |
Why?
| Self-Assessment | 2 | 2003 | 63 | 0.070 |
Why?
| Family Practice | 1 | 2010 | 418 | 0.070 |
Why?
| Software | 1 | 2010 | 532 | 0.070 |
Why?
| Infant, Newborn | 1 | 2016 | 5089 | 0.060 |
Why?
| Attitude to Health | 1 | 2009 | 410 | 0.060 |
Why?
| Health Status | 1 | 2010 | 733 | 0.060 |
Why?
| Mobile Applications | 2 | 2019 | 141 | 0.060 |
Why?
| Neuropsychological Tests | 2 | 2007 | 932 | 0.060 |
Why?
| Marijuana Abuse | 1 | 2007 | 209 | 0.060 |
Why?
| Monocytes | 1 | 2008 | 504 | 0.060 |
Why?
| Parent-Child Relations | 2 | 2004 | 236 | 0.060 |
Why?
| Societies, Medical | 2 | 2021 | 690 | 0.060 |
Why?
| Logistic Models | 3 | 2010 | 1865 | 0.060 |
Why?
| Suicide, Attempted | 1 | 2007 | 316 | 0.060 |
Why?
| Memory, Short-Term | 1 | 2007 | 225 | 0.060 |
Why?
| Mass Screening | 2 | 2011 | 1023 | 0.060 |
Why?
| Health Care Sector | 1 | 2004 | 27 | 0.060 |
Why?
| Drug Costs | 1 | 2005 | 91 | 0.060 |
Why?
| Interleukin-6 | 1 | 2008 | 679 | 0.060 |
Why?
| Administration, Intranasal | 1 | 2004 | 76 | 0.060 |
Why?
| Poverty | 2 | 2020 | 444 | 0.060 |
Why?
| Attention | 1 | 2007 | 393 | 0.060 |
Why?
| Tacrolimus | 1 | 2004 | 143 | 0.060 |
Why?
| Patient Care | 1 | 2004 | 103 | 0.060 |
Why?
| Disease Progression | 3 | 2019 | 2424 | 0.060 |
Why?
| Sensitivity and Specificity | 3 | 2019 | 1728 | 0.050 |
Why?
| Drug Utilization | 2 | 2018 | 166 | 0.050 |
Why?
| Temporal Lobe | 1 | 2003 | 83 | 0.050 |
Why?
| Self Administration | 1 | 2003 | 124 | 0.050 |
Why?
| Drug Industry | 1 | 2004 | 104 | 0.050 |
Why?
| Safety | 1 | 2005 | 298 | 0.050 |
Why?
| Motor Activity | 1 | 2007 | 636 | 0.050 |
Why?
| Amygdala | 1 | 2004 | 179 | 0.050 |
Why?
| Regression Analysis | 2 | 2016 | 961 | 0.050 |
Why?
| Activities of Daily Living | 1 | 2005 | 353 | 0.050 |
Why?
| Diagnostic Tests, Routine | 1 | 2003 | 89 | 0.050 |
Why?
| Mosaicism | 1 | 2002 | 63 | 0.050 |
Why?
| Genetic Counseling | 1 | 2002 | 67 | 0.050 |
Why?
| Alcohol Drinking | 1 | 2007 | 654 | 0.050 |
Why?
| Smoking Prevention | 1 | 2002 | 156 | 0.050 |
Why?
| Italy | 1 | 2021 | 90 | 0.050 |
Why?
| Artificial Intelligence | 1 | 2022 | 146 | 0.050 |
Why?
| Social Behavior | 1 | 2003 | 267 | 0.050 |
Why?
| Health Care Costs | 1 | 2004 | 386 | 0.050 |
Why?
| Cost of Illness | 1 | 2003 | 258 | 0.050 |
Why?
| Prenatal Diagnosis | 1 | 2002 | 167 | 0.050 |
Why?
| Immunosuppressive Agents | 1 | 2004 | 666 | 0.040 |
Why?
| Cytokines | 1 | 2008 | 1857 | 0.040 |
Why?
| Body Mass Index | 1 | 2007 | 1982 | 0.040 |
Why?
| Global Burden of Disease | 1 | 2019 | 15 | 0.040 |
Why?
| Case-Control Studies | 3 | 2019 | 3054 | 0.040 |
Why?
| Patient Selection | 1 | 2003 | 656 | 0.040 |
Why?
| Electronics | 1 | 2020 | 68 | 0.040 |
Why?
| Developmental Disabilities | 1 | 2002 | 240 | 0.040 |
Why?
| Hippocampus | 1 | 2004 | 710 | 0.040 |
Why?
| Datasets as Topic | 1 | 2019 | 100 | 0.040 |
Why?
| Homozygote | 1 | 2018 | 186 | 0.040 |
Why?
| Safety-net Providers | 1 | 2019 | 95 | 0.040 |
Why?
| Placebos | 1 | 2018 | 198 | 0.040 |
Why?
| Morbidity | 1 | 2018 | 280 | 0.040 |
Why?
| Organizational Policy | 1 | 2016 | 69 | 0.030 |
Why?
| Drug Administration Schedule | 2 | 2011 | 724 | 0.030 |
Why?
| Cognition | 1 | 2003 | 982 | 0.030 |
Why?
| Prevalence | 1 | 2002 | 2270 | 0.030 |
Why?
| Insurance Claim Review | 1 | 2016 | 67 | 0.030 |
Why?
| Diffusion of Innovation | 1 | 2016 | 94 | 0.030 |
Why?
| Intelligence Tests | 2 | 2007 | 59 | 0.030 |
Why?
| Education | 1 | 2015 | 99 | 0.030 |
Why?
| Vital Capacity | 2 | 2009 | 279 | 0.030 |
Why?
| Phenotype | 1 | 2002 | 2861 | 0.030 |
Why?
| United Kingdom | 1 | 2014 | 230 | 0.030 |
Why?
| MP3-Player | 1 | 2013 | 2 | 0.030 |
Why?
| Philadelphia | 1 | 2013 | 46 | 0.030 |
Why?
| Lung | 2 | 2023 | 3685 | 0.030 |
Why?
| Memory | 1 | 2014 | 211 | 0.030 |
Why?
| Demography | 2 | 2004 | 264 | 0.030 |
Why?
| Formoterol Fumarate | 1 | 2012 | 8 | 0.030 |
Why?
| Interview, Psychological | 1 | 2011 | 91 | 0.020 |
Why?
| Psychometrics | 2 | 2007 | 617 | 0.020 |
Why?
| Respiratory Function Tests | 1 | 2013 | 541 | 0.020 |
Why?
| Attitude of Health Personnel | 1 | 2018 | 990 | 0.020 |
Why?
| Urban Population | 1 | 2013 | 407 | 0.020 |
Why?
| Models, Organizational | 1 | 2011 | 142 | 0.020 |
Why?
| Pregnancy | 1 | 2002 | 5556 | 0.020 |
Why?
| Reproducibility of Results | 2 | 2008 | 2814 | 0.020 |
Why?
| Models, Psychological | 1 | 2011 | 299 | 0.020 |
Why?
| Emergency Medical Services | 1 | 2015 | 591 | 0.020 |
Why?
| Body Height | 1 | 2009 | 185 | 0.020 |
Why?
| Emergencies | 1 | 2009 | 150 | 0.020 |
Why?
| Statistics, Nonparametric | 1 | 2008 | 390 | 0.020 |
Why?
| False Negative Reactions | 1 | 2007 | 52 | 0.020 |
Why?
| False Positive Reactions | 1 | 2007 | 111 | 0.020 |
Why?
| Task Performance and Analysis | 1 | 2007 | 162 | 0.020 |
Why?
| Models, Statistical | 1 | 2009 | 616 | 0.020 |
Why?
| Child Behavior | 1 | 2007 | 218 | 0.020 |
Why?
| Internet | 1 | 2009 | 596 | 0.020 |
Why?
| Educational Status | 1 | 2007 | 429 | 0.020 |
Why?
| Administration, Topical | 1 | 2004 | 137 | 0.010 |
Why?
| Language Disorders | 1 | 2003 | 32 | 0.010 |
Why?
| Controlled Clinical Trials as Topic | 1 | 2003 | 27 | 0.010 |
Why?
| Magnetic Resonance Imaging | 2 | 2004 | 3087 | 0.010 |
Why?
| Dogs | 1 | 2003 | 344 | 0.010 |
Why?
| Medical Records | 1 | 2003 | 157 | 0.010 |
Why?
| Age of Onset | 1 | 2003 | 455 | 0.010 |
Why?
| Immunoglobulin E | 1 | 2003 | 363 | 0.010 |
Why?
| Disclosure | 1 | 2002 | 102 | 0.010 |
Why?
| Outpatients | 1 | 2004 | 328 | 0.010 |
Why?
| Analysis of Variance | 1 | 2004 | 1226 | 0.010 |
Why?
| Growth | 1 | 2000 | 56 | 0.010 |
Why?
| Guidelines as Topic | 1 | 2002 | 246 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 2004 | 1868 | 0.010 |
Why?
| Skin | 1 | 2004 | 668 | 0.010 |
Why?
| Multivariate Analysis | 1 | 2003 | 1444 | 0.010 |
Why?
| Cross-Sectional Studies | 1 | 2007 | 4449 | 0.010 |
Why?
|
|
Bender's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|